Romanelli, Margherita
 Distribuzione geografica
Continente #
NA - Nord America 279
EU - Europa 195
AS - Asia 70
AF - Africa 6
SA - Sud America 4
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 557
Nazione #
US - Stati Uniti d'America 279
IT - Italia 66
SE - Svezia 58
SG - Singapore 35
CN - Cina 23
IE - Irlanda 22
DE - Germania 15
RU - Federazione Russa 11
CI - Costa d'Avorio 6
HK - Hong Kong 6
GB - Regno Unito 5
RO - Romania 5
IN - India 4
BR - Brasile 3
CZ - Repubblica Ceca 3
FI - Finlandia 3
FR - Francia 2
NZ - Nuova Zelanda 2
AT - Austria 1
BE - Belgio 1
CH - Svizzera 1
CL - Cile 1
DK - Danimarca 1
EU - Europa 1
KR - Corea 1
NL - Olanda 1
TR - Turchia 1
Totale 557
Città #
Chandler 111
Dublin 22
Singapore 18
Ashburn 17
Milan 16
New York 16
Boston 12
Princeton 12
Bremen 10
Moscow 9
Chicago 7
Abidjan 6
Feasterville Trevose 5
Hong Kong 5
Rome 5
London 4
Los Angeles 4
Wilmington 4
Boydton 3
Brasov 3
Cosenza 3
Helsinki 3
Monza 3
Ansbach 2
Auckland 2
Beijing 2
Brno 2
Comelico Superiore 2
Dehradun 2
Guarulhos 2
Mountain View 2
Washington 2
Amsterdam 1
Ann Arbor 1
Bern 1
Boardman 1
Brdo 1
Brussels 1
Catania 1
Central 1
Chiswick 1
Cittadella 1
Colleferro 1
Fiumicino 1
Florence 1
Hunedoara 1
Landshut 1
Latina 1
Leawood 1
Marseille 1
Messina 1
Monmouth Junction 1
Naples 1
Nashville 1
Paris 1
Pune 1
Redwood City 1
Rimini 1
San Francisco 1
San Mateo 1
Scarsdale 1
Seoul 1
Torino 1
Vicenza 1
Vienna 1
Totale 349
Nome #
Drug Survival of IL-12/23, IL-17 and IL-23 Inhibitors for Psoriasis Treatment: A Retrospective Multi-Country, Multicentric Cohort Study 104
A 48-week update of a multicentre real-life experience of dupilumab in adult patients with moderate-to-severe atopic dermatitis 54
Real-world evidence of biologic treatments in moderate–severe psoriasis in Italy: Results of the CANOVA (EffeCtiveness of biologic treAtmeNts for plaque psOriasis in Italy: An obserVAtional longitudinal study of real-life clinical practice) study 51
A real-world economic analysis of biologic therapies for moderate-to-severe plaque psoriasis in Italy: results of the CANOVA observational longitudinal study 47
Secukinumab shows high efficacy irrespective of HLA-Cw6 status in patients with moderate-to-severe plaque-type psoriasis: results from extension phase of the SUPREME study 42
Dupilumab therapy of atopic dermatitis of the elderly: a multicentre, real-life study 39
Ultrasonography in the pathway to an optimal standard of care of hidradenitis suppurativa: the Italian Ultrasound Working Group experience 37
Real-life experience on effectiveness and safety of dupilumab in adult patients with moderate-to-severe atopic dermatitis 36
Improving the disease awareness: how a communication campaign brings hidradenitis suppurativa to the light 34
Effectiveness and Safety of Long-Term Dupilumab Treatment in Elderly Patients with Atopic Dermatitis: A Multicenter Real-Life Observational Study 30
Age and gender influence on HIDRAdisk outcomes in adalimumab-treated hidradenitis suppurativa patients 27
Comorbidities and treatment patterns in adult patients with atopic dermatitis: results from a nationwide multicenter study 26
Real-World Apremilast Use for Treatment of Plaque Psoriasis in Italy: Patient Perspective, Characteristics, and Clinical Outcomes from the DARWIN Study 16
Long-term Effectiveness and Safety of Upadacitinib for Atopic Dermatitis in a Real-world Setting: An Interim Analysis Through 48 Weeks of Observation 11
Correction to: Comorbidities and treatment patterns in adult patients with atopic dermatitis: results from a nationwide multicenter study (Archives of Dermatological Research, (2022), 314, 6, (593-603), 10.1007/s00403-021-02243-w) 11
AtopyReg®: the prospective Italian patient registry for moderate to severe atopic dermatitis in adults by SIDeMaST 10
Totale 575
Categoria #
all - tutte 4.013
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.013


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202112 0 0 0 0 0 0 0 8 0 1 3 0
2021/202299 27 0 9 1 4 0 0 6 1 1 24 26
2022/2023253 28 33 15 38 20 32 9 28 33 3 9 5
2023/2024186 5 31 16 22 14 25 10 5 3 8 26 21
2024/202525 16 8 1 0 0 0 0 0 0 0 0 0
Totale 575